NPM1 mutation detection
Absolute RT-PCR quantification assays were performed using forward and reverse primers for exon 12 of NPM1 and three specific probes for detecting type A, type B and type D mutations.
Primers and probes used for NPM1 mutation detection: 
BAALC expression
Comparative RT-PCR assays (7900HT RT-PCR System) were performed using BAALC primers and probes (Applied Biosystems). The comparative cycle threshold (Ct) method was used to determine the relative expression level of BAALC, and ABL was used as endogenous internal control for each sample. One patient sample was used as positive control, and set at 1, and was included in each run for standardization. Relative BAALC expression values were calculated as: 2 -mΔΔCt with mΔΔCt = mΔCt x patient -mΔCt positive control. Forward and reverse primers and probes were designed and provided by Applied Biosystems.
CEBPA mutations detection
Genescan assay: TAD1, TAD2 and bZIP domains were amplified by PCR and labeled using 50ng DNA, 1X_PCR buffer containing 1.5mM MgCl2, 5% dimethylsulfoxide, 0.20mM of each dNTP, 0.4U of Taq-Gold DNA polymerase (Applied Biosystems) and 500nM of specific primers. The mixture was heated at 95°C for 10 min and subjected to 30 PCR cycles (60 s at 95°C, 40 s at 55°C and 90 s at 72°C) with a final extension of 5 min at 72°C.
After amplification, 2 mL of each product were added to 10 mL formamide and 1 mL of GeneScan 500 size marker (Applied Biosystems) followed by a denaturation step (5 min at 95°C) and immediate cooling on ice. Capillary electrophoresis was performed on ABI 3130xl genetic analyzer (Applied Biosystems) using POP7 polymer. Data were analyzed with GeneMapper software v.4.0.
List of primers for GeneScan assay: TAD1 Forward: 5'-TCGGCCGACTTCTACGAGGC-3' Reverse: 5'-ACTTTGACTACCCGGGCGC-3' TAD2 Forward: 5'-TACCTGGACGGCAGGCTGGA-3' Reverse: 5'-AGACCACCATGCACCTGCA-3' bZIP Forward: 5'-AGAAGTCGGTGGACAAGAACAGCAA-3' Reverse: 5'-GTCAAGGCCATGGGCAACT-3'
HRM analysis on Light Cycler 480 (Roche Applied Sciences™) and sequencing:
Four fragments covering the whole CEBPA coding sequence were amplified using 15µg/mL DNA, 0.5 mM of each primer, SensiMix™ HRM kit (BIOLINE) containing EvaGreen™ DNA binding dye, and 0.5M GC-rich resolution solution (Roche Applied Sciences™). Amplification was performed by 50 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 30 s, followed by High Resolution Melting program, consisting in 95°C for 1 min, 40°C for 1 min, and 25 acquisitions per 1°C during the melting phase (from 75°C to 99°C).
All patient samples were analyzed and compared to 2 wildtype samples used as reference. All samples with abnormal melting profiles were directly sequenced using a 3130XL-DNA sequencing system (Applied Biosystems ™). Sequences were analyzed with SeqScape software (Applied Biosystems™). 10 (5) 2 (5) 8 (5) M1 43 (21) 10 (24) 33 (21) M2 51 (25) 13 (30) 38 (24) M4 29 (14) 1 (2) 28 (17) M5 40 (20) 6 (15) 34 (22) M6 5 (2) 1 (2) 
List of primers for HRM assay

